Fred Telling - Aug 8, 2023 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role
Director
Signature
/s/ Mark A. Catchur, as Attorney-in-Fact for Frederick W. Telling
Stock symbol
OGEN
Transactions as of
Aug 8, 2023
Transactions value $
$0
Form type
4
Date filed
8/10/2023, 04:30 PM
Previous filing
Aug 2, 2022
Next filing
Dec 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGEN Common Stock Award $0 +25K +148.41% $0.00 41.8K Aug 8, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock pursuant to the Company's non-employee director compensation program under the Company's 2021 Equity Incentive Plan with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months.
F2 Reflects adjustments made in connection with the 1-for-60 reverse stock split of the Issuer's common stock which became effective on January 23, 2023